L&R Medical

Lohmann & Rauscher (L&R) is an active international medical device and healthcare products company focused on wound management, bandages and supports, compression therapy, set systems, and hygiene products. The requested name "L&R Medical" most likely refers to Lohmann & Rauscher, which commonly uses the abbreviation L&R, but it is not the company’s exact canonical name. The company develops, manufactures, and distributes a broad portfolio of more than 60,000 products for hospitals, clinicians, and patient care settings. Its commercial portfolio includes advanced wound care brands such as Debrisoft and Suprasorb, as well as compression and procedure-pack offerings. L&R operates globally with multiple subsidiaries, production sites, and distribution partners, and has expanded through acquisitions including Unisurge in 2025. It is a healthcare company, but not a biotech or therapeutics developer; its business is centered on commercial medical devices and care solutions rather than a drug pipeline.